Keith J.  Sullivan net worth and biography

Keith Sullivan Biography and Net Worth

Director of Venus Concept
Keith Sullivan has served as the Chief Commercial Officer of Restoration Robotics since November 2018 and as a member of the board of directors since July 2018. Mr. Sullivan previously served as Chief Commercial Officer and President (North America) of ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform under the Coolsculpting® brand, from January 2016 until the acquisition of ZELTIQ by Allergan, Inc. in April 2017. Mr. Sullivan previously served as Senior Vice President and Chief Commercial Officer of ZELTIQ from November 2014 until January 2016 and as Senior Vice President of Worldwide Sales and Marketing from July 2013 through October 2014. Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry, has previously held leadership positions with Medicis Pharmaceuticals, Reliant Technologies, Medtronic, Vision Quest Laser Center and Coherent Medical. Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary.

What is Keith J. Sullivan's net worth?

The estimated net worth of Keith J. Sullivan is at least $948,244.10 as of February 26th, 2024. Mr. Sullivan owns 1,372,278 shares of Venus Concept stock worth more than $948,244 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Sullivan may own. Learn More about Keith J. Sullivan's net worth.

How do I contact Keith J. Sullivan?

The corporate mailing address for Mr. Sullivan and other Venus Concept executives is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. Venus Concept can also be reached via phone at (888) 907-0115 and via email at [email protected]. Learn More on Keith J. Sullivan's contact information.

Has Keith J. Sullivan been buying or selling shares of Venus Concept?

Keith J. Sullivan has not been actively trading shares of Venus Concept during the past quarter. Most recently, on Wednesday, December 15th, Keith J. Sullivan bought 5,333 shares of Venus Concept stock. The stock was acquired at an average cost of $18.75 per share, with a total value of $99,993.75. Learn More on Keith J. Sullivan's trading history.

Who are Venus Concept's active insiders?

Venus Concept's insider roster includes Yoni Iger (VP), Ross Portaro (Insider), Domenic Serafino (CEO), and Keith Sullivan (Director). Learn More on Venus Concept's active insiders.

Keith J. Sullivan Insider Trading History at Venus Concept

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2021Buy5,333$18.75$99,993.75View SEC Filing Icon  
See Full Table

Keith J. Sullivan Buying and Selling Activity at Venus Concept

This chart shows Keith J Sullivan's buying and selling at Venus Concept by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Venus Concept Company Overview

Venus Concept logo
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $0.69
Low: $0.68
High: $0.76

50 Day Range

MA: $1.03
Low: $0.64
High: $1.86

2 Week Range

Now: $0.69
Low: $0.60
High: $4.70

Volume

36,671 shs

Average Volume

580,698 shs

Market Capitalization

$3.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66